摘要: |
基于研发联盟组合的视角探究了企业研发合作伙伴技术多样性对企业突破性创新的作用机制,并依据社会网络理论分析了伙伴平均关系强度和伙伴平均社会价值的调节作用。采用1997—2017年中国医药制造业上市企业的专利数据进行实证分析,得到如下结论:研发合作伙伴技术多样性对企业突破性创新的作用为倒U形;伙伴平均关系强度减弱了伙伴技术多样性与企业突破性创新的倒U形关系;伙伴平均社会价值增强了伙伴技术多样性与企业突破性创新的倒U形关系。研究结论不仅完善了现有关于伙伴技术多样性对企业创新结果影响不一致的结论,而且丰富了对联盟组合研究的探讨,并对企业管理者构建和管理联盟组合提出了建议。 |
关键词: 研发合作伙伴 技术多样性 伙伴平均关系强度 伙伴平均社会价值 企业突破性创新 |
DOI:10.13581/j.cnki.rdm.20191945 |
分类号:F270.7 |
基金项目:国家自然科学基金面上项目“组织搜索视角下的企业研发行为变革及其绩效影响研究”(71572143)。 |
|
Technological Diversity of Alliance Partners and Firms' Breakthrough InnovationModerating Effect of R&D Alliance Portfolio's Characters |
BI Jing-yu1, XIE En2, WEI Hai-xiao1
|
1.School of Management, Xi’an Jiaotong University, Xi’an 710049, China;2.School of Economics & Management, Tongji University, Shanghai 200092, China
|
Abstract: |
Based on the R&D alliance portfolio view, it attempted to further examine the effect of technological diversity of R&D alliance portfolio on firms’ breakthrough innovation, and also explored the moderating effect of partners’ average tie strength and partners’ average social value. The empirical study, leveraging the Chinese listed biopharmaceutical firms during 1997 to 2017, reveals that technological diversity of R&D alliance portfolio imposes an inverted U shaped effect on firms’ breakthrough innovation; partners’ average tie strength weakens while partners’ average social value strengthens the inverted U shaped relationship between technological diversity and firms’ breakthrough innovation. Relevant research results not only supply the existing inconsistent conclusions about how technological diversity of R&D partners influence firms’ innovation outcomes, but also enrich the existing literature of alliance portfolio. Meanwhile, the findings provide useful reference for managers of the focal firms to build and manage R&D alliance portfolios. |
Key words: R&D partner technological diversity partners’ average tie strength partners’ average social value firms’ breakthrough innovation |